Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

OncXerna Therapeutics

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
2018
11-50
Waltham, Massachusetts, United States
BiopharmaBiotechnologynologyHealth CareMedical DevicePharmaceuticalsPrecision Medicine

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

127.M

Last Funding Amount

30.M

Last Funding Date

03-03-2022

Lead Investors

Panacea Venture, Korea Investment Partners, Volcanics Venture, KB Investment, K2 HealthVentures

Revenue

$1M to $10M

People

Founders